Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3643712
Max Phase: Preclinical
Molecular Formula: C19H24F3NO4
Molecular Weight: 387.40
Molecule Type: Small molecule
Associated Items:
ID: ALA3643712
Max Phase: Preclinical
Molecular Formula: C19H24F3NO4
Molecular Weight: 387.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCO[C@@H]1C[C@@]2(CC[C@H]1O)CCN(c1ccc(OCC(F)(F)F)cc1)C2=O
Standard InChI: InChI=1S/C19H24F3NO4/c1-2-26-16-11-18(8-7-15(16)24)9-10-23(17(18)25)13-3-5-14(6-4-13)27-12-19(20,21)22/h3-6,15-16,24H,2,7-12H2,1H3/t15-,16-,18-/m1/s1
Standard InChI Key: DHPMSQPFKXIQSS-JFIYKMOQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 387.40 | Molecular Weight (Monoisotopic): 387.1657 | AlogP: 3.30 | #Rotatable Bonds: 5 |
Polar Surface Area: 59.00 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.61 | CX LogD: 2.61 |
Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.84 | Np Likeness Score: -0.24 |
1. (2014) SEC-hydroxycyclohexyl derivatives, |
Source(1):